PRKCA and diabetic kidney disease: To study the involvement of PKCα in proteinuria development in diabetic nephropathy, we treated mice after streptozotocin induced diabetes with a synthetic PKCα inhibitor (GÖ6976), which could prevent proteinuria development and led to preserved nephrin expression.